Salivary Oxytocin and Vasopressin Levels in Police Officers With and Without Post-Traumatic Stress Disorder

Journal of Neuroendocrinology

Volumn 27, Issue 10, 2015, Pages 743-751

  Frijling, J L ^a   van Zuiden, M ^a   Nawijn, L ^a   Koch, S B J ^a   Neumann, I D ^b   Veltman, D J ^c   Olff, M ^a,d  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ARQ PSYCHOTRAUMA EXPERT GROUP   (Netherlands)

Author keywords

Childhood trauma; Oxytocin; PTSD; Stress; Vasopressin

Indexed keywords

ARGIPRESSIN; NEUROPEPTIDE; OXYTOCIN; VASOPRESSIN DERIVATIVE;

ADULT; ARTICLE; CHECKLIST; CHILD ABUSE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; EARLY TRAUMA INVENTORY; EMOTIONAL ABUSE; FEMALE; HORMONAL CONTRACEPTION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; JOB STRESS; MALE; POLICE; POLICE LIFE EVENT CHECKLIST; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RADIOIMMUNOASSAY; SALIVA LEVEL; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; PSYCHOLOGY; SALIVA;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OXYTOCIN; POLICE; SALIVA; STRESS DISORDERS, POST-TRAUMATIC; VASOPRESSINS;

EID: 84941888474     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/jne.12300     Document Type: Article

References (54)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Arlington, VA: American Psychiatric Publishing, 2013.
2. Morris MC, Compas BE, Garber J. Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: a systematic review and meta-analysis. Clin Psychol Rev 2012; 4: 301-315.
3. Hayes JP, Hayes SM, Mikedis AM. Quantitative meta-analysis of neural activity in posttraumatic stress disorder. Biol Mood Anxiety Disord 2012; 9: 1-13.
4. Olff M, Langeland W, Witteveen A, Denys D. A psychobiological rationale for oxytocin in the treatment of posttraumatic stress disorder. CNS Spectr 2010; 8: 522-530.
5. Neumann ID, Landgraf R. Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors. Trends Neurosci 2012; 11: 649-659.
6. Wotjak CT, Kubota M, Liebsch G, Montkowski A, Holsboer F, Neumann I, Landgraf R. Release of vasopressin within the rat paraventricular nucleus in response to emotional stress: a novel mechanism of regulating adrenocorticotropic hormone secretion? J Neurosci 1996; 23: 7725-7732.
7. Young LJ, Wang Z. The neurobiology of pair bonding. Nat Neurosci 2004; 10: 1048-1054.
8. Bielsky IF, Young LJ. Oxytocin, vasopressin, and social recognition in mammals. Peptides 2004; 9: 1565-1574.
9. Calcagnoli F, de Boer SF, Althaus M, den Boer JA, Koolhaas JM. Antiaggressive activity of central oxytocin in male rats. Psychopharmacology 2013; 4: 639-651.
10. Wigton R, Radua J, Allen P, Averbeck B, Meyer-Lindenberg A, McGuire P, Shergill SS, Fusar-Poli P. Neurophysiological effects of acute oxytocin administration: systematic review and meta-analysis of placebo-controlled imaging studies. J Psychiatry Neurosci 2015; 1: E1-E22.
11. Heinrichs M, Meinlschmidt G, Neumann I, Wagner S, Kirschbaum C, Ehlert U, Hellhammer DH. Effects of suckling on hypothalamic-pituitary-adrenal axis responses to psychosocial stress in postpartum lactating women. J Clin Endocrinol Metab 2001; 10: 4798-4804.
12. Cardoso C, Kingdon D, Ellenbogen MA. A meta-analytic review of the impact of intranasal oxytocin administration on cortisol concentrations during laboratory tasks: moderation by method and mental health. Psychoneuroendocrinology 2014; 49: 161-170.
13. van Ijzendoorn MH, Bakermans-Kranenburg MJ. A sniff of trust: meta-analysis of the effects of intranasal oxytocin administration on face recognition, trust to in-group, and trust to out-group. Psychoneuroendocrinology 2012; 3: 438-443.
14. Shalev I, Israel S, Uzefovsky F, Gritsenko I, Kaitz M, Ebstein RP. Vasopressin needs an audience: neuropeptide elicited stress responses are contingent upon perceived social evaluative threats. Horm Behav 2011; 1: 121-127.
15. Thompson R, Gupta S, Miller K, Mills S, Orr S. The effects of vasopressin on human facial responses related to social communication. Psychoneuroendocrinology 2004; 1: 35-48.
16. Zoicas I, Slattery DA, Neumann ID. Brain oxytocin in social fear conditioning and its extinction: involvement of the lateral septum. Neuropsychopharmacology 2014; 39: 3027-3035.
17. Acheson D, Feifel D, de Wilde S, Mckinney R, Lohr J, Risbrough V. The effect of intranasal oxytocin treatment on conditioned fear extinction and recall in a healthy human sample. Psychopharmacology 2013; 1: 199-208.
18. Eckstein M, Becker B, Scheele D, Scholz C, Preckel K, Schlaepfer TE, Grinevich V, Kendrick KM, Maier W, Hurlemann R. Oxytocin facilitates the extinction of conditioned fear in humans. Biol Psychiatry 2015; 78: 194-202.
19. Milad MR, Pitman RK, Ellis CB, Gold AL, Shin LM, Lasko NB, Zeidan MA, Handwerger K, Orr SP, Rauch SL. Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder. Biol Psychiatry 2009; 12: 1075-1082.
20. De Kloet C, Vermetten E, Geuze E, Wiegant V, Westenberg H. Elevated plasma arginine vasopressin levels in veterans with posttraumatic stress disorder. J Psychiatr Res 2008; 3: 192-198.
21. Marshall AD. Posttraumatic stress disorder and partner-specific social cognition: a pilot study of sex differences in the impact of arginine vasopressin. Biol Psychol 2013; 2: 296-303.
22. Seng J, Miller J, Sperlich M, van de Ven CJM, Brown S, Carter CS, Liberzon I. Exploring dissociation and oxytocin as pathways between trauma exposure and trauma-related hyperemesis gravidarum: a test-of-concept pilot. J Trauma Dissociation 2013; 1: 40-55.
23. Olff M, Frijling JL, Kubzansky LD, Bradley B, Ellenbogen MA, Cardoso C, Bartz JA, Yee JR, van Zuiden M. The role of oxytocin in social bonding, stress regulation and mental health: an update on the moderating effects of context and interindividual differences. Psychoneuroendocrinology 2013; 9: 1883-1894.
24. Lucas-Thompson RG, Holman EA. Environmental stress, oxytocin receptor gene (OXTR) polymorphism, and mental health following collective stress. Horm Behav 2013; 4: 615-624.
25. Veenema AH, Bredewold R, Neumann ID. Opposite effects of maternal separation on intermale and maternal aggression in C57BL/6 mice: link to hypothalamic vasopressin and oxytocin immunoreactivity. Psychoneuroendocrinology 2007; 5: 437-450.
26. Wismer Fries AB, Ziegler TE, Kurian JR, Jacoris S, Pollak SD. Early experience in humans is associated with changes in neuropeptides critical for regulating social behavior. Proc Natl Acad Sci USA 2005; 47: 17237-17240.
27. Heim C, Young LJ, Newport DJ, Mletzko T, Miller AH, Nemeroff CB. Lower CSF oxytocin concentrations in women with a history of childhood abuse. Mol Psychiatry 2009; 10: 954-958.
28. Bertsch K, Schmidinger I, Neumann ID, Herpertz SC. Reduced plasma oxytocin levels in female patients with borderline personality disorder. Horm Behav 2013; 3: 424-429.
29. Bhandari R, Bakermans-Kranenburg MJ, van der Veen R, Parsons CE, Young KS, Grewen KM, Stein A, Kringelbach ML, van IJzendoorn MH. Salivary oxytocin mediates the association between emotional maltreatment and responses to emotional infant faces. Physiol Behav 2014; 28: 123-128.
30. de Vries GJ, Olff M. The lifetime prevalence of traumatic events and posttraumatic stress disorder in the Netherlands. J Trauma Stress 2009; 4: 259-267.
31. Salonia A, Nappi RE, Pontillo M, Daverio R, Smeraldi A, Briganti A, Fabbri F, Zanni G, Rigatti P, Montorsi F. Menstrual cycle-related changes in plasma oxytocin are relevant to normal sexual function in healthy women. Horm Behav 2005; 2: 164-169.
32. Cyranowski JM, Hofkens TL, Frank E, Seltman H, Cai HM, Amico JA. Evidence of dysregulated peripheral oxytocin release among depressed women. Psychosom Med 2008; 9: 967-975.
33. Dhakar MB, Stevenson EL, Caldwell HK. Oxytocin, vasopressin, and their interplay with gonadal steroids. In: Choleris E, Pfaff DW, Kavaliers M, eds. Oxytocin, Vasopressin and Related Peptides in the Regulation of Behavior. Cambridge: Cambridge University Press, Cambridge, UK, 2013: 3-36.
34. American Psychiatric Association. DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders, text revision. Arlington, VA: American Psychiatric Association, 2000.
35. Forsling ML. Diurnal rhythms in neurohypophysial function. Exp Physiol 2000; 85: 179S-186S.
36. Kagerbauer S, Martin J, Schuster T, Blobner M, Kochs E, Landgraf R. Plasma oxytocin and vasopressin do not predict neuropeptide concentrations in human cerebrospinal fluid. J Neuroendocrinol 2013; 7: 668-673.
37. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, Keane TM. The development of a Clinician-Administered PTSD Scale. J Trauma Stress 1995; 1: 75-90.
38. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59: 22-33.
39. ® Axis I Disorders (SCID-I), Clinician Version, Administration Booklet. Arlington, VA: American Psychiatric Publishing, 2012.
40. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370.
41. Bremner JD, Bolus R, Mayer EA. Psychometric properties of the early trauma inventory-self report. J Nerv Ment Dis 2007; 3: 211-218.
42. Carlier I, Gersons B. Development of a scale for traumatic incidents in police work. Psychiatrica Fennica 1992; 23: 59-70.
43. Hoffman ER, Brownley KA, Hamer RM, Bulik CM. Plasma, salivary, and urinary oxytocin in anorexia nervosa: a pilot study. Eat Behav 2012; 3: 256-259.
44. Yuen KW, Garner JP, Carson DS, Keller J, Lembke A, Hyde SA, Kenna HA, Tennakoon L, Schatzberg AF, Parker KJ. Plasma oxytocin concentrations are lower in depressed vs. healthy control women and are independent of cortisol. J Psychiatr Res 2014; 51: 30-36.
45. Ozsoy S, Esel E, Kula M. Serum oxytocin levels in patients with depression and the effects of gender and antidepressant treatment. Psychiatry Res 2009; 3: 249-252.
46. Modahl C, Green LA, Fein D, Morris M, Waterhouse L, Feinstein C, Levin H. Plasma oxytocin levels in autistic children. Biol Psychiatry 1998; 4: 270-277.
47. Green L, Fein D, Modahl C, Feinstein C, Waterhouse L, Morris M. Oxytocin and autistic disorder: alterations in peptide forms. Biol Psychiatry 2001; 8: 609-613.
48. van Londen L, Goekoop JG, van Kempen GM, Frankhuijzen-Sierevogel AC, Wiegant VM, van derVelde EA, De Wied D. Plasma levels of arginine vasopressin elevated in patients with major depression. Neuropsychopharmacology 1997; 4: 284-292.
49. Schlossberg K, Massler A, Zalsman G. Environmental risk factors for psychopathology. Isr J Psychiatry Relat Sci 2010; 2: 49.
50. Carson D, Berquist S, Trujillo T, Garner J, Hannah S, Hyde S, Sumiyoshi R, Jackson L, Moss J, Strehlow M. Cerebrospinal fluid and plasma oxytocin concentrations are positively correlated and negatively predict anxiety in children. Mol Psychiatry 2014; Nov 4. doi: 10.1038/mp.2014.132. [Epub ahead of print].
51. Toth I, Neumann ID, Slattery DA. Central administration of oxytocin receptor ligands affects cued fear extinction in rats and mice in a timepoint-dependent manner. Psychopharmacology 2012; 2: 149-158.
52. Picavet C. Zwangerschap en anticonceptie in Nederland. Tijdschrift voor Seksuologie 2012; 2: 121-128.
53. Szeto A, McCabe PM, Nation DA, Tabak BA, Rossetti MA, McCullough ME, Schneiderman N, Mendez AJ. Evaluation of enzyme immunoassay and radioimmunoassay methods for the measurement of plasma oxytocin. Psychosom Med 2011; 73: 393-400.
54. McCullough ME, Churchland PS, Mendez AJ. Problems with measuring peripheral oxytocin: can the data on oxytocin and human behavior be trusted? Neurosci Biobehav Rev 2013; 8: 1485-1492.